Literature DB >> 9492098

Walker-Warburg syndrome: neurologic features and muscle membrane structure.

R J Kanoff1, R G Curless, C Petito, S Falcone, R M Siatkowski, E Pegoraro.   

Abstract

Walker-Warburg syndrome is an autosomal-recessive genetic disorder characterized by congenital muscular dystrophy in association with complex developmental abnormalities of the central nervous system and the eyes. Two patients with Walker-Warburg syndrome are presented to demonstrate clinical variability. Previously unreported pathologic findings involving heart, muscle, spinal cord, and gall bladder are described, and the literature is reviewed. Histopathologic studies of the muscle membrane protein network in both Walker-Warburg syndrome patients reveal a decreased immunostaining for laminin alpha2 and beta-dystroglycan. The clinical, histologic, and biochemical variability in Walker-Warburg patients may reflect heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9492098     DOI: 10.1016/s0887-8994(97)00137-9

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  9 in total

1.  Walker-Warburg Syndrome: A Case with multiple uncommon features.

Authors:  Hibba A Bedri; Babiker M Mustafa; Yosif M Jadallah
Journal:  Sudan J Paediatr       Date:  2011

2.  Dystroglycan organizes axon guidance cue localization and axonal pathfinding.

Authors:  Kevin M Wright; Krissy A Lyon; Haiwen Leung; Daniel J Leahy; Le Ma; David D Ginty
Journal:  Neuron       Date:  2012-12-06       Impact factor: 17.173

Review 3.  Pediatric neurodegenerative white matter processes: leukodystrophies and beyond.

Authors:  Jonathan A Phelan; Lisa H Lowe; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2008-04-30

4.  Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast.

Authors:  Jakob S Satz; Rita Barresi; Madeleine Durbeej; Tobias Willer; Amy Turner; Steven A Moore; Kevin P Campbell
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

5.  Mutational and functional analysis of Large in a novel CHO glycosylation mutant.

Authors:  Jennifer T Aguilan; Subha Sundaram; Edward Nieves; Pamela Stanley
Journal:  Glycobiology       Date:  2009-05-21       Impact factor: 4.313

6.  Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome.

Authors:  Daniel Beltrán-Valero de Bernabé; Sophie Currier; Alice Steinbrecher; Jacopo Celli; Ellen van Beusekom; Bert van der Zwaag; Hülya Kayserili; Luciano Merlini; David Chitayat; William B Dobyns; Bru Cormand; Ana-Elina Lehesjoki; Jesús Cruces; Thomas Voit; Christopher A Walsh; Hans van Bokhoven; Han G Brunner
Journal:  Am J Hum Genet       Date:  2002-10-04       Impact factor: 11.025

7.  Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.

Authors:  Ute Hehr; Goekhan Uyanik; Claudia Gross; Maggie C Walter; Axel Bohring; Monika Cohen; Barbara Oehl-Jaschkowitz; Lynne M Bird; Ghiat M Shamdeen; Ulrich Bogdahn; Gerhard Schuierer; Haluk Topaloglu; Ludwig Aigner; Hanns Lochmüller; Jürgen Winkler
Journal:  Neurogenetics       Date:  2007-09-29       Impact factor: 2.660

8.  Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency.

Authors:  M Pane; S Messina; G Vasco; A R Foley; L Morandi; E Pegoraro; T Mongini; A D'Amico; F Bianco; M E Lombardo; R Scalise; C Bruno; A Berardinelli; A Pini; I Moroni; M Mora; A Toscano; M Moggio; G Comi; F M Santorelli; E Bertini; F Muntoni; E Mercuri
Journal:  Neuromuscul Disord       Date:  2012-06-22       Impact factor: 4.296

9.  ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome.

Authors:  Tobias Willer; Hane Lee; Mark Lommel; Takako Yoshida-Moriguchi; Daniel Beltran Valero de Bernabe; David Venzke; Sebahattin Cirak; Harry Schachter; Jiri Vajsar; Thomas Voit; Francesco Muntoni; Andrea S Loder; William B Dobyns; Thomas L Winder; Sabine Strahl; Katherine D Mathews; Stanley F Nelson; Steven A Moore; Kevin P Campbell
Journal:  Nat Genet       Date:  2012-05       Impact factor: 38.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.